DNAPrint Genomics Inc logo

DNAG - DNAPrint Genomics Inc Share Price

$0.001 0.0  0.0%

Last Trade - 7:58pm

Sector
Healthcare
Size
Micro Cap
Market Cap £274k
Enterprise Value £4.11m
Revenue £1.37m
Position in Universe th / 6714
Bullish
Bearish
Unlock DNAG Revenue
Momentum
Relative Strength (%)
1m +48.2%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -40.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2001 2002 2003 2004 2005 2006 2007E 2008E CAGR / Avg
0.000 0.19 0.71 0.79 1.28 2.43 +90.4%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2007,DNAPrint Genomics, Inc. revenues decreased 26% to $1.4M.Net loss decreased 92% to $690K. Revenues reflect adecrease in demand for the Company's products and servicesdue to unfavorable market conditions. Lower net lossreflects Gain on sale of investments available fo increasefrom $0K to $4.4M (income), Research & Development decreaseof 37% to $3.3M (expense), Intr. Value of Conv.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

DNAG Revenue Unlock DNAG Revenue

Net Income

DNAG Net Income Unlock DNAG Revenue

Normalised EPS

DNAG Normalised EPS Unlock DNAG Revenue

PE Ratio Range

DNAG PE Ratio Range Unlock DNAG Revenue

Dividend Yield Range

DNAG Dividend Yield Range Unlock DNAG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
DNAG EPS Forecasts Unlock DNAG Revenue
Profile Summary

DNAPrint genomics, Inc. is a development-stage pharmaceutical company. As of March 15, 2007, the Company’s pharmacogenomics products were still in development. The Company generates revenues in its consumer, forensic and genotyping services, but these services have not resulted in the generation of significant revenues. During the year ended December 31, 2006, the Company’s revenues were from the sales of its ancestry product, AncestryByDNA and genotyping services. The Company provides services that range from sequencing and genotyping to the entire process of single nucleotide polymorphisms (SNP) discovery to large industrial customers. Contract genotyping is the process of reading a genetic sequence and identifying differences in the sequence letters. This information helps researchers understand how human differences are expressed at the gene level.

Directors
Last Annual December 31st, 2006
Last Interim September 30th, 2007
Incorporated August 11, 1983
Public Since February 23, 2001
No. of Shareholders: 1,034
No. of Employees: 24
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 644,609,919
Free Float (0.0%)
Eligible for
ISAs
SIPPs
DNAG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for DNAG
Upcoming Events for DNAG
Frequently Asked Questions for DNAPrint Genomics Inc
What is the DNAPrint Genomics Inc share price?

As of 7:58pm, shares in DNAPrint Genomics Inc are trading at $0.001, giving the company a market capitalisation of £274k. This share price information is delayed by 15 minutes.

How has the DNAPrint Genomics Inc share price performed this year?

Shares in DNAPrint Genomics Inc are currently trading at $0.001 and the price has moved by 0.500k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the DNAPrint Genomics Inc price has moved by 0.380k% over the past year.

What are the analyst and broker recommendations for DNAPrint Genomics Inc?

There are no analysts currently covering DNAPrint Genomics Inc.

When will DNAPrint Genomics Inc next release its financial results?

DNAPrint Genomics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2008-09-30
What is the DNAPrint Genomics Inc dividend yield?

DNAPrint Genomics Inc does not currently pay a dividend.

Does DNAPrint Genomics Inc pay a dividend?

DNAPrint Genomics Inc does not currently pay a dividend.

When does DNAPrint Genomics Inc next pay dividends?

DNAPrint Genomics Inc does not currently pay a dividend.

How do I buy DNAPrint Genomics Inc shares?

To buy shares in DNAPrint Genomics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of DNAPrint Genomics Inc?

Shares in DNAPrint Genomics Inc are currently trading at $0.001, giving the company a market capitalisation of £274k.

Where are DNAPrint Genomics Inc shares listed? Where are DNAPrint Genomics Inc shares listed?

Here are the trading details for DNAPrint Genomics Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: DNAG
What kind of share is DNAPrint Genomics Inc?

We were not able to load our ranking data for DNAPrint Genomics Inc

Is there a DNAPrint Genomics Inc share price forecast 2021?

We were not able to load any forecast data for DNAPrint Genomics Inc.

How can I tell whether the DNAPrint Genomics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DNAPrint Genomics Inc. Over the past six months, the relative strength of its shares against the market has been 0.415k%. At the current price of $0.001, shares in DNAPrint Genomics Inc are trading at 0.364k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the DNAPrint Genomics Inc PE Ratio?

We were not able to find PE ratio data for DNAPrint Genomics Inc.

Who are the key directors of DNAPrint Genomics Inc?

DNAPrint Genomics Inc's management team is headed by:

Tony Frudakis - CSO
Hector Gomez - CHM
Karen Surplus - CAO
Who are the major shareholders of DNAPrint Genomics Inc?

Here are the top five shareholders of DNAPrint Genomics Inc based on the size of their shareholding:

Filbrandt Wealth Management, LLC Investment Advisor
Percentage owned: % (n/a shares)
North Star Asset Management Inc. Investment Advisor
Percentage owned: % (n/a shares)
Similar to DNAG
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.